<DOC>
	<DOCNO>NCT02240030</DOCNO>
	<brief_summary>This randomize , multicenter , placebo-controlled , double-blind study evaluate efficacy safety inhale CVT 301 compare placebo PD patient experience motor response fluctuation ( OFF phenomenon ) outpatient ( i.e. , home ) clinic . Patients successfully complete study eligible enroll 12 month treatment extension ( CVT-301-004E ) study .</brief_summary>
	<brief_title>Efficacy Safety Study CVT-301 In Parkinson 's Disease Patients With OFF Episodes</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease ( PD ) diagnose age 30 85 year ; Hoehn Yahr Stage 13 `` '' state ; Require levodopacontaining medication regimen least 3 time waking day ; Experience motor fluctuation minimum 2 hour average daily `` '' time per wake day ( exclude early morning `` '' time ) demonstrate levodopa responsiveness ; Are stable PD medication regimen ; Total daily LD dose &lt; 1600 mg/day ; Able perform spirometry maneuver ON OFF state ; Normal cognition confirm MMSE score â‰¥25 Pregnant lactating female ; Previous surgery PD plan stereotactic surgery study period ; History psychotic symptom require treatment , suicide ideation attempt within last year ; Known contraindication use levodopa ; Any significant condition , severe concurrent disease , abnormality find would make patient unsuitable may compromise patient safety ; Any contraindication perform routine spirometry .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>Motor fluctuation</keyword>
	<keyword>levodopa</keyword>
	<keyword>inhale drug</keyword>
	<keyword>OFF episode</keyword>
</DOC>